Jake Simson is a Partner at RA Capital Management who works on both public and private investments. He currently serves as a Board Director for Xenikos, B.V, Tyra Biosciences, and AavantiBi. Previously, Jake covered solid tumor oncology landscapes. Jake holds a BS in Materials Science and Engineering from MIT and a PhD in Biomedical Engineering from Johns Hopkins University. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels.
This person is not in the org chart